FDA issues warning letter to Boehringer Ingelheim API plant

10:39 AM | May 22, 2013 | Deepti Ramesh

FDA issued a warning letter earlier this month to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facility Boehringer Ingelheim (Ingelheim am Rhein, Germany) at...